Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Orchard Therapeutics (ORTX) - Total debt
Total debt on the balance sheet as of September 2023 : $47.82 M
According to Orchard Therapeutics 's latest financial reports the company's total debt is $47.82 M. A company’s total debt is the sum of all current and non-current debts.
Orchard Therapeutics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $58.09 M | -2.35% |
| 2021-12-31 | $59.48 M | 2.27% |
| 2020-12-31 | $58.16 M | 26.7% |
| 2019-12-31 | $45.91 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $1.5 M | -96.86% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $47.82 M | 0.00% | 🇬🇧 UK |
 Novavax NVAX | $0.22 B | 379.05% | 🇺🇸 USA |
 Novocure
NVCR | $0.59 B | 1,146.85% | Jersey |